Back to search

Democritus University of Thrace (DUTH)

Μελέτη της συσχέτισης της εντερικής μικροχλωρίδας και του υποκείμενου ανοσολογικού συστήματος σε ασθενείς με ΙΦΝΕ με σκοπό την ανάδειξη νέων θεραπευτικών προσεγγίσεων

Abstract

dc:description

Crohn’s Disease and Ulcerative Colitis are the main Inflammatory Bowel Diseases (IBDs) and are characterized by chronic and remitting colonic inflammation leading to the disrupted architecture of the intestinal tissue, which could also result in the development of fibrosis. HT-29 epithelial cell line is widely used as an in vitro model of the immunopathological mechanisms regarding gut barrier integrity and inflammation, which are main pathophysiological characteristics observed in patients with IBD. In addition, colonic subepithelial myofibroblasts (cSEMFs) are actively involved in mucosal wound healing and inflammation and are proven to be key mediators causing fibrotic disposition during IBD. Probiotic supplements have the prospect of being used as auxiliary treatment for IBDs, with the bacterial strains Bifidobacterium lactis, Bifidobacterium longum, Heyndrickxia coagulans, Lactobacillus acidophilus, Lactiplantibacillus plantarum, Lacticaseibacillus rhamnosus and the fungal strain Saccharomyces boulardii being commonly found amongst them. The main aim of the present thesis was to study the impact of the aforementioned probiotic strains, alone and in premade mixtures, in widely used cell models of IBD, in order to assess the potency of them being used as an auxiliary IBD treatment. This aim was achieved by assessing these probiotic strains’ effect on the proliferation rate and mRNA expression of pro-inflammatory CXCL8 and of tight junctions proteins in HT-29 cell line as well as their impact on the inflammatory and healing capacity of primary cSEMFs isolated from healthy individuals, from patients with Crohn’s Disease and from patients with Ulcerative Colitis.HT-29 cells were stimulated with 102 or 104 or 108 cfu/mL of the aforementioned probiotic strains alone and in various combinations for 6 hours, and their effect on the mRNA expression of the pro-inflammatory chemokine CXCL8 and on the mRNA expression of tight junctions’ proteins Claudin1, JAMA, Occludin and Zonula Occludens 1 was assessed by qRT-PCR. HT-29 were also pre-stimulated for 24 hours with IL-1α (5ng/ml) and TNF-α (50ng/ml) and then 102 or 104 or 108 cfu/mL of the mixture of Bifidobacterium lactis, Lactobacillus acidophilus, Lactiplantibacillus plantarum and Saccharomyces boulardii were added for another 6 hours, in order to study the mRNA expression of these same factors. Furthermore, HT-29 cells were stimulated with 102 or 104 cfu/mL of these probiotics for 48 hours in order to assess their effect on the proliferation rate of HT-29 using Wound Healing Assay. In addition, gut biopsies from healthy individuals, from patients with Crohn’s Disease and from patients with Ulcerative Colitis were obtained and single-cell colonies of primary cSEMFs were isolated and further cultured. cSEMFs were then stimulated with 102 or 104 cfu/mL of the aforementioned probiotic strains alone and in combinations, and their effect on chemokines (CCL2, CCL5, CCL20, CXCL1, CXCL2, CXCL3, CXCL4, CXCL5, CXCL6, CXCL7, CXCL8, CXCL9, CXCL10, CXCL11, CXCL12, CXCL14), cytokines (IL-1α, IL-1β, IL-6, IL-10, IL-22, IL-24, IL-26, IL-32α, IL-33, IFN-γ, TNF-α) and wound healing factors (Collagen Type I, Collagen Type III, Fibronectin, Tissue Factor, α-Smooth Muscle Actin) was assessed by qRT-PCR (mRNA expression, 6-hour stimulation), ELISA (chemokine protein levels, 48-hour stimulation) and Sircol Assay (secreted collagen, 48-hour stimulation), as well as on cSEMFs migration rate, by Wound Healing Assay. The probiotic strains and mixtures studied in this thesis remained viable and altered the inflammatory and healing behavior of both HT-29 and of the cSEMFs isolated from healthy individuals and from IBD patients. In detail, the probiotic mix of B. lactis, L. acidophilus, L. plantarum, S. boulardii was added to unstimulated or IL-1α and TNF-α pre-stimulated ΗΤ-29 and it was shown that it does not alter neither the mRNA expression of the proteins of tight junctions ClDN1, JAMA, OCLN and ZO-1, nor the mRNA expression of CXCL8. Regarding the mRNA of CXCL8, its expression was promoted when HT-29 were stimulated with L. plantarum and with the higher dosage 108 cfu/mL of H. coagulans and was reduced by the lower concentrations of H. coagulans, as well as by stimulation with S. boulardii, with the mixture of B. longum and L. rhamnosus and with the mixture of B. longum, L. rhamnosus and L. acidophilus. The mRNA and protein expression of the studied chemokines and healing factors in cSEMFs isolated from healthy individuals was dependent on the strain or strains used, and their dosage. More specifically, 102 cfu/mL of B. lactis reduced the mRNA expression of CXCL1, CXCL2 and CXCL6, while 104 cfu/mL of B. lactis promoted the mRNA expression of CCL2, CCL5, CXCL1 and CXCL2. Stimulation with the strain L. acidophilus downregulated the mRNAs of CXCL2, CXCL6 and CXCL8 and upregulated the mRNA of CXCL10. L. plantarum stimulation resulted in augmenting both the mRNA and the protein expression of CXCL8 as well as the mRNA expression of CXCL10. Probiotic fungus S. boulardii increased the mRNA expression of CCL5 and CXCL5. Moving on to the expression of healing factors, the mRNAs of Collagen type Ι, Collagen type ΙΙΙ, Fibronectin and Tissue Factor were upregulated by L. plantarum stimulation and downregulated by L. acidophilus stimulation. The cSEMFs’ mRNA expression of Collagen type ΙΙΙ was also decreased by B. lactis and S. boulardii, while B. lactis also decreased the mRNA of Fibronectin. In addition, S. boulardii stimulation promoted the mRNA expression of Tissue Factor and the protein secretion of collagen of cSEMFs. Finally, stimulating healthy individuals’ cSEMFs with the mixture of B. lactis, L. acidophilus, L. plantarum, S. boulardii resulted in the non-statistically significant upregulation of the mRNA of the chemokines CXCL1, CXCL2, CXCL4, CXCL8, CXCL10, CCL2 and CCL5, in the upregulation of the mRNAs of Fibronectin and Tissue Factor as well as in the downregulation of the mRNA of α-SMA. It is worth mentioning that the mRNA expression of the cytokines ΙL-6, IL-8, IL-24 and IL-32 was non-statistically significantly increased in unstimulated cSEMFs isolated from patients with Crohn’s Disease, and adding the mixture of B. lactis, L. acidophilus, L. plantarum, S. boulardii did not further alter it, except for the slight upregulation of the mRNA of IL-24.Specifically, regarding 48-hour stimulations with the single probiotic strains, the results of the present thesis show that the bacteria B. lactis, H. coagulans and the fungus S. boulardii appear to promote the proliferation rate of HT-29 cell line. Regarding the 48-hour effect of single strains on cSEMFs isolated from healthy individuals, B. lactis, L. plantarum, S. boulardii and the lower dosage of H. coagulans promote their migratory capacity, contrary to B. longum, L. rhamnosus and the higher dosage of H. coagulans that reduce it. L. plantarum and S. boulardii stimulations also increase the migratory rate of cSEMFs isolated from patients with Crohn’s Disease but do not affect the migratory rate of cSEMFs isolated from patients with Ulcerative Colitis. It is worth mentioning that despite the aforementioned various effects observed by using different strains, the stimulations with the mixtures containing these probiotic strains appeared to exert more balanced results on HT-29 proliferation and cSEMFs healing capacities. In more detail, the mixture of B. longum and L. rhamnosus and the mixture of B. lactis and L. acidophilus promote the proliferation of HT-29, and so does the mixture of B. longum, L. acidophilus and L. rhamnosus, for the first 24 hours, although it reduces it at the end of the 48-hour incubation. The lower dosage 102 cfu/mL of the probiotic mixture of B. lactis, L. acidophilus, L. plantarum and S. boulardii also reduces the proliferation of the HT-29, but this effect is apparent only for the first 24h. As far as healthy individuals cSEMFs’ migratory rate is concerned, it is promoted by the mixture of B. longum and L. rhamnosus and the higher dosage 104 cfu/mL of the probiotic mixture of B. lactis, L. acidophilus, L. plantarum and S. boulardii, while it is reduced by the mixture of B. lactis and L. acidophilus and the lower dosage 102 cfu/mL of the probiotic mixture of B. lactis, L. acidophilus, L. plantarum and S. boulardii. Similarly, the migration rate of cSEMFs from patients with Crohn’s Disease and of cSEMFs from patients with Ulcerative Colitis is promoted by the mixture of B. lactis, L. acidophilus, L. plantarum and S. boulardii. The mixture of B. longum and L. rhamnosus was shown to reduce the migratory capacity of cSEMFs from patients with Crohn’s Disease too. In conclusion, the effects of the probiotic strains and mixtures varied significantly, with greater increase or decrease in chemokine, cytokine and healing factor expression. However, this thesis confirms that the results of the probiotics are dependent on each specific strain (or combination of strains) and the concentration that was administered. Overall, this study highlights that the use of multiple probiotic strains can potentially alert the gut mucosal immune system and promote wound healing, having a more beneficial effect on mucosal immunity than the use of single probiotics.

Degree

thesis:*
Grantor dc:publisher
Democritus University of Thrace (DUTH)
Year dc:date
2025

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Tarapatzi, Gesthimani
  • Ταραπατζή, Γεσθημανή

Subjects

dc:subject × 20

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/58367

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Tarapatzi, Gesthimani; Ταραπατζή, Γεσθημανή. Μελέτη της συσχέτισης της εντερικής μικροχλωρίδας και του υποκείμενου ανοσολογικού συστήματος σε ασθενείς με ΙΦΝΕ με σκοπό την ανάδειξη νέων θεραπευτικών προσεγγίσεων. Democritus University of Thrace (DUTH), 2025. http://hdl.handle.net/10442/hedi/58367